Boston Scientific Corporation (LON:0HOY)
London · Delayed Price · Currency is GBP · Price in USD 100.64
+2.54 (2.59%)
At close: Nov 25, 2025
Boston Scientific Market Cap
Boston Scientific has a market cap or net worth of 113.98 billion as of November 26, 2025. Its market cap has increased by 13.27% in one year.
Market Cap
113.98B
Enterprise Value
122.33B
Revenue
14.39B
Ranking
n/a
PE Ratio
54.90
Stock Price
100.64
Market Cap Chart
Since May 19, 1992, Boston Scientific's market cap has increased from 876.49M to 113.98B, an increase of 12,904.38%. That is a compound annual growth rate of 15.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 113.98B | 8.40% |
| Dec 31, 2024 | 105.15B | 58.15% |
| Dec 29, 2023 | 66.49B | 20.88% |
| Dec 30, 2022 | 55.00B | 23.04% |
| Dec 31, 2021 | 44.71B | 18.57% |
| Dec 31, 2020 | 37.70B | -20.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.31B |
| GSK plc | 71.84B |
| Haleon | 33.60B |
| Smith & Nephew | 10.61B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.86B |
| Genus | 1.65B |